How Dynamics 365 Business Central Supports Regulatory Audits in Pharmaceutical Manufacturing

Pharmaceutical manufacturers must maintain accurate records of materials, inventory movements, production activities, and business transactions. When an audit or inspection takes place, finding the right information quickly can become difficult if records are spread across spreadsheets, disconnected systems, and manual approval processes.

Microsoft Dynamics 365 Business Central can support pharmaceutical audit readiness by improving transaction traceability, recording selected data changes, managing access permissions, and standardizing business approvals. 

These capabilities can help teams retrieve information more efficiently and establish clearer accountability across relevant business processes.

However, an ERP system alone does not guarantee pharmaceutical regulatory compliance. Audit readiness also depends on documented procedures, appropriate system configuration, data integrity controls, validation where required, and the manufacturer's quality management processes.

Why Pharmaceutical Manufacturers Struggle with Audit Readiness

Audit preparation becomes more complicated when business records are maintained across different tools or departments. Common challenges include:

• Incomplete traceability: Teams struggle to connect received materials, inventory transactions, and related documents.

• Limited visibility into changes: It can be difficult to establish who changed a particular business record and when, especially if change tracking was not configured.

• Inconsistent approval processes: Purchase, inventory, or financial transactions may follow different approval practices across teams.

• Scattered documentation: Supporting invoices, receipts, and other business records may be stored in different locations.

• Time-consuming evidence retrieval: Employees spend time collecting records manually instead of preparing a clear, consistent audit trail.

  
  

These challenges can delay audit preparation and make it harder for teams to demonstrate how their business processes are controlled.

How Dynamics 365 Business Central Supports Pharmaceutical Audit Readiness

Business Central provides ERP capabilities that can support recordkeeping, traceability, and operational control. The value depends on how the system is configured and which processes it manages.

1. Change Logs for Greater Accountability

Business Central includes a Change Log feature that can record selected changes to configured tables and fields. The resulting entries can help teams review what changed and when, along with the associated user information.

For pharmaceutical businesses, this may support reviews of relevant business records, such as selected item, vendor, or financial data.

What manufacturers should verify:

• Which tables and fields are configured for change logging.

• Whether the selected tracking scope covers the records required by internal procedures.

• Who can access change-log entries and how they are reviewed.

• Whether retention and performance considerations have been addressed.

  
  

Change logging is configurable; it should not be assumed to capture every action or every change made throughout the business. It also should not be treated as a complete, validated pharmaceutical audit-trail solution without assessing the applicable requirements.

Microsoft reference: Audit changes in Business Central.

2. Lot and Serial Number Tracking for Inventory Traceability

Lot and serial number tracking can help manufacturers identify and trace inventory through relevant inbound and outbound transactions. Depending on configuration and the transaction history, teams can use Business Central's item-tracking features to investigate where tracked items were received, moved, or shipped.

This can be useful when reviewing material movements, investigating inventory discrepancies, or gathering records related to a product or batch.

Manufacturers should consider configuring and testing:

• Lot or serial number assignment for applicable items.

• Tracking requirements across relevant purchasing, inventory, and sales processes.

• Expiration-date handling where applicable and configured.

• The availability and completeness of historical transaction records.

  
  

Important: Lot tracking in an ERP system is not automatically the same as complete pharmaceutical batch genealogy. If the business needs to connect raw materials to specific production batches, finished products, quality-test results, and released batches, it should verify whether standard functionality, additional configuration, or a manufacturing or quality-management extension is required.

Microsoft references: Set up item tracking and Trace item-tracked items.

3. Role-Based Permissions and Access Control

Pharmaceutical businesses need clear responsibility for who can create, edit, approve, and review business records. Business Central provides user permissions and permission sets that can help restrict access to data and functions.

Appropriate access controls can support internal accountability and reduce the risk of unauthorized changes to business information.

Manufacturers should review:

• Which users can access sensitive records and functions.

• Whether responsibilities are appropriately separated.

• Who can configure permissions and change-log settings.

• Whether access rights are reviewed when employees change roles or leave.

  
  

Access permissions must be designed and tested against the manufacturer's operating procedures. They do not, by themselves, establish regulatory compliance or guarantee segregation of duties in every process.

Microsoft reference: Security auditing in Business Central.

4. Approval Workflows for Consistent Business Processes

Business Central supports configurable approval workflows for supported business documents and processes. Depending on the setup, organizations can define who must approve particular transactions and under what conditions.

For example, a manufacturer may configure approval steps for purchase orders or other relevant business transactions to make responsibilities clearer and reduce reliance on informal email-based approvals.

Before relying on these workflows, teams should confirm:

• Which documents and transactions require approval.

• Who is authorized to approve each type of transaction.

• How exceptions, rejected requests, and delegated approvals are handled.

• Whether the workflow history and supporting records meet internal documentation requirements.

Standard ERP approval workflows should not be confused with formal pharmaceutical quality processes, such as batch disposition, deviation closure, or change control, unless those processes have been specifically designed and validated for the intended use.

5. Supporting Documents and Business Records

Audit preparation often requires more than a transaction number. Employees may also need to locate purchase orders, invoices, receipts, and other supporting business documents.

Business Central can associate documents and attachments with relevant records in supported scenarios. This can help teams retrieve business evidence from a more connected operational environment.

Manufacturers should decide which records belong in Business Central, which must remain in a dedicated document or quality-management system, and how the systems will be linked.

They should also define document ownership, retention, access, version control, and retrieval procedures. Storing a file alongside an ERP transaction does not automatically make it a controlled quality document or establish compliance with electronic-record requirements.

6. Reporting and Evidence Retrieval

Business Central's transaction records, filters, and reporting capabilities can help employees review business activity and assemble relevant information for internal reviews or audits.

For example, teams may need to review inventory movements, purchase transactions, item-tracking records, or selected changes to business data.

Useful reporting depends on having complete and consistently maintained records. Organizations should establish standard procedures for retrieving the information they need, checking its accuracy, and documenting any limitations.

Where audit evidence must combine ERP transactions with laboratory results, quality events, manufacturing execution data, or other specialized records, additional integrations or reporting tools may be necessary.

What Pharmaceutical Manufacturers Must Verify Before an Audit

Business Central can support important business controls, but pharmaceutical manufacturers should assess the entire process rather than relying on a feature list.

Before an audit, review the following:

• Traceability: Can the team retrieve the relevant item, lot, or transaction history?

• Change records: Are the required tables and fields configured for logging, and are the records available for review?

• Access permissions: Are user roles and sensitive permissions appropriate for each person's responsibilities?

• Approvals: Do configured workflows reflect the organization's documented approval procedures?

• Documentation: Can employees retrieve the required supporting records and demonstrate how they are maintained?

• System validation: Has the system been assessed, tested, and validated where required for its intended regulated use?

• Record retention: Are retention, retrieval, backup, and access procedures defined for the applicable records?

• System boundaries: Are additional controls, integrations, or specialist quality-management solutions required?

  
  

This assessment helps identify gaps between what the ERP system provides and what the manufacturer's procedures and regulatory obligations require.

Pharmaceutical Regulatory Considerations in India

Pharmaceutical manufacturers in India must comply with the regulatory requirements applicable to their products and operations. Relevant frameworks include the Drugs and Cosmetics Act, 1940, the Drugs Rules, 1945, and applicable Good Manufacturing Practices (GMP) requirements under Schedule M.

Schedule M addresses pharmaceutical manufacturing practices and requirements relating to areas such as the pharmaceutical quality system, documentation, premises, equipment, and manufacturing controls. Manufacturers should consult the applicable rules and notifications to determine the requirements that apply to their facilities and products.

Dynamics 365 Business Central may support selected business-record, traceability, access-control, and approval processes. However, Business Central should not be described as automatically making a pharmaceutical manufacturer GMP-compliant. Compliance depends on the manufacturer's complete quality system, the intended use of the software, system configuration, validation where required, and documented operating procedures.

Regulatory obligations can vary by market, product category, and intended use. Companies exporting medicines should also assess the requirements of each destination market rather than assuming that Indian requirements cover all jurisdictions.

A Practical Checklist for Improving Audit Readiness

Pharmaceutical manufacturers can use the following steps to assess whether their ERP-supported business processes are ready for an audit.

Step 1: Map the Relevant Records

Identify the business transactions and supporting records required for the audit. Establish which systems hold each record and who is responsible for maintaining it.

Step 2: Review Lot and Serial Tracking

Check that applicable items use the correct tracking setup and that relevant historical transactions can be retrieved. Test representative scenarios rather than assuming that tracking is complete.

Step 3: Assess Change Logging

Confirm that the required tables and fields are included in the Change Log configuration. Verify that the team can retrieve and interpret the entries needed for internal review.

Step 4: Review User Permissions

Check access to sensitive data, approval functions, and system configuration. Resolve unnecessary permissions and document the review according to internal procedures.

Step 5: Test Approval Workflows

Walk through representative transactions to confirm that approvals follow the documented process. Review exceptions and ensure that relevant records can be retrieved.

Step 6: Test Evidence Retrieval

Ask the responsible team to retrieve a sample of records within a defined period. Check that the information is complete, consistent, and supported by the necessary documents.

Step 7: Document Gaps and Corrective Actions

Record missing information, configuration issues, process gaps, and any additional system requirements. Assign owners and target dates for corrective actions, and retain evidence of completion.

Key Takeaways

Dynamics 365 Business Central can contribute to pharmaceutical audit readiness by helping organizations manage business transactions, track selected inventory movements, record configured data changes, apply access permissions, and standardize supported approval processes.

The key is to align those capabilities with documented procedures and the manufacturer's regulatory obligations. Lot tracking is not automatically full batch genealogy, a Change Log is not automatically a complete regulated audit trail, and an approval workflow is not a substitute for a validated quality-management process.

A structured review of configuration, records, access controls, validation needs, and system integrations can help pharmaceutical manufacturers identify gaps before an audit.

For pharmaceutical manufacturers evaluating Business Central, the starting point is understanding how purchasing, inventory, finance, traceability, reporting, and existing quality systems work together and identifying where configuration, integration, or additional functionality may be needed.

Want to understand where your current Business Central setup has gaps? Contact our team to discuss an ERP configuration and process-readiness review. We can help assess the business-system side of your setup and identify areas that may need further technical or specialist compliance evaluation.